Literature DB >> 28647952

Children with Short Stature and Growth Failure: Heightism, Gender and Racial Disparities.

Terri H Lipman1, Ian J McCurry2.   

Abstract

Growth is the single most important indication of the health of a child. Identification of growth disorders in all children is crucial as growth failure can be the first sign of a number of acute and chronic conditions. However, gender and racial biases have resulted in inequities in the identification, referral and treatment of children with growth disorders. In addition, short children have been impacted by a number of psychosocial issues. Heightism is prejudice or discrimination against individuals based on height, and refers to discrimination against individuals whose height is not within the normal acceptable range. Studies have shown that short children have been affected by juvenilization, teasing, bullying, victimization, loss of independence/ overprotection, and exclusion. The role of the advanced practice nurse is critical in addressing heightism and racial and gender disparities in children with growth failure/short stature. Copyright© of YS Medical Media ltd.

Entities:  

Keywords:  Children; Gender disparities; Growth failure; Heightism; Linear growth; Racial disparities

Mesh:

Year:  2017        PMID: 28647952     DOI: 10.17458/per.vol14.2017.lm.childrenshortstature

Source DB:  PubMed          Journal:  Pediatr Endocrinol Rev        ISSN: 1565-4753


  2 in total

1.  Editorial: Hot Topics of Debate on Turner Syndrome: Growth, Puberty, Cardiovascular Risks, Fertility and Psychosocial Development.

Authors:  Ahmet Uçar; Jarod Sze Choong Wong; Feyza Darendeliler; Jeff M P Holly; Derek Leroith
Journal:  Front Endocrinol (Lausanne)       Date:  2019-09-19       Impact factor: 5.555

Review 2.  Identifying and addressing disparities in the evaluation and treatment of children with growth hormone deficiency.

Authors:  Kara Beliard; Vickie Wu; Julie Samuels; Terri H Lipman; Robert Rapaport
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-24       Impact factor: 6.055

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.